Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aneurysm III: Interprofessional Care

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessment of Recipient Renal Transplant Arterial Graft Supply in the Immediate Postoperative Period (≤1 week): A Systematic Review.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Same author

Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

The Annals of thoracic surgery·2026

Same author

The rationale for a randomized trial for uncomplicated Type B aortic dissection.

Seminars in vascular surgery·2026

Same author

Equipoise: The basic necessity for conducting a trial on uncomplicated Type B aortic dissection.

Seminars in vascular surgery·2026

Same author

Are society guidelines the best we have?

Seminars in vascular surgery·2026

Same author

Should Type B intramural hematoma be treated like Type B aortic dissection? A narrative review.

Seminars in vascular surgery·2026

Search research articles

Related Experiment Video

Updated: Jan 17, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Contemporary randomized controlled trials in uncomplicated type B aortic dissection: a comparative methodological

Tasnia Rahman¹, Colin D Bicknell², Firas F Mussa³

¹Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland - tasnia.rahman@helsinki.fi.

The Journal of Cardiovascular Surgery

|September 19, 2025

Summary

This summary is machine-generated.

Thoracic endovascular aortic repair (TEVAR) is being evaluated against best medical therapy for uncomplicated type B aortic dissection. Ongoing trials will clarify TEVAR's role in aortic remodeling and long-term outcomes.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Related Experiment Videos

Last Updated: Jan 17, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Area of Science:

Cardiovascular Surgery
Vascular Medicine
Medical Technology Assessment

Background:

Uncomplicated type B aortic dissection (uTBAD) management is debated.
Best medical therapy (BMT) is conventional, but thoracic endovascular aortic repair (TEVAR) offers potential remodeling benefits.
Conflicting evidence on TEVAR's survival, risks, and durability limits adoption.

Purpose of the Study:

To compare three major randomized controlled trials (IMPROVE-AD, EARNEST, SUNDAY) evaluating TEVAR for uTBAD.
To analyze trial designs, inclusion criteria, interventions, and outcome measures.
To contextualize TEVAR's evolving role and inform future clinical practice.

Main Methods:

Comparative analysis of three ongoing randomized controlled trials: IMPROVE-AD, SUNDAY, and EARNEST.
Examination of study designs, patient cohorts, intervention protocols (TEVAR vs. BMT), and outcome measures.
Synthesis of methodologies to predict the impact on clinical practice and guidelines.

Main Results:

IMPROVE-AD assesses TEVAR vs. BMT for mortality and complications in 1,100 patients over six years.
SUNDAY focuses on subacute uTBAD, evaluating remodeling, safety, and survival.
EARNEST integrates clinical, anatomical, economic, and quality-of-life endpoints.

Conclusions:

Results from IMPROVE-AD, SUNDAY, and EARNEST are anticipated to significantly influence uTBAD management guidelines.
These trials are expected to refine patient selection criteria for TEVAR.
The long-term benefits and risks of TEVAR in uTBAD will be clarified, guiding future treatment strategies.